Page last updated: 2024-09-02

rx 821002 and 2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole

rx 821002 has been researched along with 2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole in 1 studies

Compound Research Comparison

Studies
(rx 821002)
Trials
(rx 821002)
Recent Studies (post-2010)
(rx 821002)
Studies
(2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole)
Trials
(2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole)
Recent Studies (post-2010) (2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole)
317045705

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cardinaletti, C; Carrieri, A; Farande, A; Gentili, F; Ghelfi, F; Giannella, M; Huhtinen, A; Laurila, JM; Piergentili, A; Pigini, M; Quaglia, W; Scheinin, M; Vesprini, C1

Other Studies

1 other study(ies) available for rx 821002 and 2-(1-(2-allylphenoxy)ethyl)-4,5-dihydro-1h-imidazole

ArticleYear
Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; CHO Cells; Cricetinae; Cricetulus; Magnetic Resonance Spectroscopy; Mice; Rats; Receptors, Adrenergic, alpha-2

2008